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The fabrication of functional nanoscale devices requires the construction of complex 
architectures at length scales characteristic of atoms and molecules. Currently microlithography 
and micro-machining of macroscopic objects are the preferred methods for construction of small 
devices, but these methods are limited to the micron scale. An intriguing approach to nanoscale 
fabrication involves the association of individual molecular components into the desired 
architectures by supramolecular assembly. This process requires the precise specification of 
intermolecular interactions, which in turn requires precise control of molecular structure. 
Organic polymers offer several advantages as materials for the construction of small-scale 
devices, including ease of synthesis and fabrication, well-delineated structure-property 
correlations, and thermal and mechanical stability. However the ability to precisely define 
polymer architecture is severely restricted for all but the most simple sequences. Macromolecular 
structure is defined in terms of four architectural variables: molecular size, composition, 
sequence, and stereochemistry . The degree to which these variables can be controlled depends on 
the method of polymer synthesis; conventional methods of polymer synthesis afford only 
statistical control of each. Consequently most synthetic polymers are not pure substances but 
instead comprise heterogeneous populations of molecular species, and significant advances in the 
solution and solid state properties of polymeric materials have been associated with increased 
degree of control over one or more of the architectural variables. For example, the stereoregular 
polymerization of a-olefins by the Ziegler-Natta procedure revolutionized polymer materials 
science by providing high melting, crystalline materials from simple, inexpensive building b1ocks.l 
In general, the synthesis of complex architectures is limited by the few available methods for the 
synthesis of precisely defined macromolecular architectures. 
Polymers of uniform structure are synthesized by either of two techniques: iterative 
coupling of selectively activated monomers? or template-directed polymerization.3 The former 
process consists of stepwise assembly of the desired material via a repetitive sequence of 
intermolecular coupling and activation steps (Scheme I). Two reactive endgroups are coupled 
intermolecularly, and one of the remaining endgroups is selectively deprotected. The process is 
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repeated with addition of new reactants and the desired molecule is assembled sequentially. The 
serial nature of this process ensures that the microstructure of the polymer is determined by the 
identity of the individual reactants at each step. This process has found application in the 
assembly of complex structures both in solution and on solid supports. The former has been 
used, for example, in the synthesis of dendritic macromolecules~ and the latter procedure forms 
the basis for the Merrifield synthesis of polypeptides.5 However, owing to the linear nature of 
the process, the degree of synthetic difficulty increases geometrically with the length ( and 
thereby the complexity ) of the sequence. This feature, coupled with the lack of an intrinsic 
proof-reading mechanism, limits this process to the synthesis of moderate length polymers, e.g., 
sixty residues for a polypeptide sequence. 
In contrast to the iterative coupling procedure, template-directed synthesis can provide an 
intrinsic proof-reading capacity, and therefore a self-correction mechanism. In this procedure, a 
master template is used to specify the exact sequence of the target polymer, which is then 
assembled in a parallel process fiom the component monomers (Scheme 11). The template can 
direct the synthesis of many copies of the target polymer by dissociation of the complementary 
polymer and repetition of the process. This procedure is currently limited in scope by the 
availability of suitably designed templates, which ideally must be uniform polymers themselves, 
and by formulation of appropriate mechanisms for the transfer of sequence information from the 
template to the reactive monomers. The best realized example of this process is protein 
biosynthesis, in which a DNA sequence serves as a template for the synthesis of the 
polypeptide chain through the intermediacy of a complementary mRNA sequence (Figure 1). 
The sequence information specifying any given protein is encoded in a particular DNA 
sequence in the host organism. Under appropriate conditions, a copy of the coding sequence is 
transcribed as a messenger RNA (mRNA). The triplet codons of the mRNA, each specifying a 
particular amino acid residue, are then sequentially decoded on the ribosome by specifically 
amino-acylated transfer RNA molecules. This procedure serves as the mechanism for coupling 
the DNA sequence information to that of the polypeptide. Near-absolute specificity of all of the 
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aforementioned structural parameters, e.g., size, composition, sequence, and stereochemistry, is 
ensured for the nascent polypeptide not only by the template polymerization mechanism but 
also by simultaneous proof-reading steps that occur during the transcription/translation process. 
Thus polypeptides derived from genetic templates may be considered as model uniform 
polymers. 
Polypeptides also differ from most synthetic polymers in that they adopt ordered three- 
dimensional structures in solution and in the solid state. Most naturally occuning proteins adopt 
globular structures consistent with their roles in substrate recognition and transformation, for 
example, as enzymes. However a number of naturally occuning proteins have fibrous structures 
and serve as structural components in vivo. These proteins are essentially polymeric in the 
classical sense, consisting of tandem repeats of oligomeric peptide sequences. Yet these proteins 
are synthesized by the same mechanism and exhibit the same uniformity of structure as their 
more complex globular counterparts. In addition, these polypeptides also adopt regular and 
persistent secondary structures in both the solution and solid states, consistent with the 
geometrical requirements of their oligopeptide repeats. 
By utilizing the principles of protein structure and the concepts of material science as 
guides, non-natural protein-based materials can be designed that are capable of self-assembly into 
unique two- or three-dimensional shapes on the basis of their primary structures. The sequence 
of a polypeptide chain contains sufficient information to direct its specific assembly into a 
particular native conformation. The driving force for this process is the non-covalent, primarily 
hydrophobic interaction occuning between segments of the polypeptide chain. These 
interactions act cooperatively to direct the formation and association of secondary structure 
elements, e.g., a-helix, P-sheet, and reverse turn, into the native structure. The known 
preferences for the formation of specific secondary structures by particular amino acid sequences 
provide a pattern for the de novo design of protein materials. Novel combinations of secondary 
structure can be programmed into the polypeptide sequence to generate unique geometries in the 
folded protein. These dimensionally-defined protein materials may serve as subunits for the 
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hierarchical construction of nanoscale objects and devices. In addition, a diverse repertoire of 
functional groups may be incorporated into these materials, comprising the side chain 
functionalities of both natural and non-natural amino acid residues, providing geometrically- 
defined sites for further interaction between individual protein subunits. 
Artificial protein sequences can be synthesized with absolute uniformity of structure by 
utilizing the techniques of recombinant DNA technology and bacterial protein expression (Figure 
2).637 A fundamental oligopeptide repeat, designed for its ability to adopt a particular fold in the 
fmal material, is encoded into a double-stranded DNA sequence. The oligonucleotide repeat is 
generated by solid-state synthesis and then sequenced to verify its integrity. Ligation of the ends 
of the oligonucleotide in a specific head-to-tail fashion affords a population of DNA multimers 
that contain tandem repeats of the c o h g  sequence. Fractionation generates the target length 
multimer (the artificial gene), which is inserted into a plasmid, an autonomously replicating, 
extrachromosomal circular genetic element. The plasmid also contains a gene that confers 
resistance to a particular antibiotic and thus provides a method for selection of transformed cells. 
The recombinant plasmid is then introduced into a bacterial strain ( most typically Escherichia 
coli ) that is capable of expression of the target protein. When cultured in the presence of an 
appropriate antibiotic, only bacteria that produce the products of the recombinant plasmid 
survive and grow. The transformed bacteria are grown to a particular cell density and target 
protein production is induced. The cells are harvested and lysed, and the target protein is then 
purified from the host proteins. Yields of up to grams of protein per liter of culture have been 
obtained in this manner. 
Methods of this kind have now been used to prepare natural structural proteins as well as 
artificial proteins that have no direct parallel in nature. The remaining sections of this chapter 
summarize the state of the art of bacterial expression of protein-like polymers of potential utility 
in nanoscale fabrication of structures and devices. 
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EXPRESSION OF STRUCTURAL PROTEINS 
Introduction 
Natural structural proteins, e.g. silk, collagen, elastin, and keratin, are ubiquitous and 
essential to the proper function of all organisms. Natural evolutionary processes have yielded 
proteins that surpass the performance of man-made materials, e.g. mammalian elastin in the 
cardiovascular system that lasts half a century without loss of function, and spider webs 
composed of silk threads that are tougher than any synthetic fiber.6 There has been much recent 
interest in understanding and producing these natural polymers to make products for commercial 
applications. Purification of the biological materials fkom natural sources can be complicated or 
impossible in some cases. For example, adhesive proteins used by marine organisms to attach 
themselves to surfaces are irreversibly cross-linked upon secretion and cannot then be processed 
or reused! Isolation of structural proteins from biological sources (e.g. collagen) is practiced on a 
large scale commercially, yet the physical properties of those extracted materials are often less 
than optimal. Furthermore, problen~s in processing these materials combined with inconsistent 
quality and limited sources act to restrict commercial use of natural structural proteins to a few 
applications (e.g. photographic gelatin and cosmetic fillers). 
As an alternative method to achieve production of large quantities of well-defined 
structural proteins, many researchers have turned to biocatalytic polymer synthesis using genetic 
engineering.6.7 Two approaches to the synthesis of natural polymers through this technique are 
(i) to clone the complementary DNA which encodes the protein of interest fiom the source 
organism and then express the resulting gene and (ii) to utilize or create a consensus repeat fiom 
highly repetitive proteins to construct a corresponding DNA sequence ("monomer1') which is 
described in the previous section. This second procedure has been widely employed since it 
avoids the need to obtain cDNA clones and since it permits selection of codons to avoid unstable 
repetitive sequences and adaptation of codon usage to the requirements of the host organism. 
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Many natural structural proteins or artificial proteins designed to ninic  natural materials have 
been successfully expressed in microorganisms and one such product has been commercialized.6 
Silks 
The silk fibroin of the common silk caterpillar Bombyx mori consists of extensive beta 
strands which hydrogen bond to form sheets? As such, the protein chains are very densely 
packed and are also highly oriented in silk fibers resulting in hlgh tensile strength. B. mori silk 
fibroin primarily consists of tandem repeats of the sequence (GlyAlaGlyAlaGlySer-) and this 
has been the repeat sequence targeted for production of materials having the properties of silk 
fibers. Joseph Cappello and coworkers at Protein Polymer Technologies, Inc. (PPTI) have 
reported the expression in E. coli of high molecular weight (40-100 kDa) proteins that 
incorporate blocks of the B. mori silk hexapeptide repeat.6 These recombinant proteins were 
shown to be c~ystalline with structures similar to the beta sheet structures found in natural silk. 
Fibers prepared from these samples were found to contain beta sheet structures but no molecular 
orientation or alignment was seen for any of the samples. This is a limitation which must be 
overcome to attain and assess the ultimate physical properties of these silk-like polymers. 
Sequences derived from elastin (ValProGlyValGly-) or from the cell-binding portion of 
fibronectin (-ArgGlyAspSer-) have also incorporated into silk-like polymers.6 The result is that 
the elastin blocks lower the crystallinity of the polymers and enhance their solubility and 
processability. The incorporation of the fibronectin sequence into silk-like polymers creates a 
useful substrate material for cell culture. This polymer can be coated on plastic or glass surfaces 
and subjected to sterilization at high temperature and pressure without loss of activity. This 
material has been prepared in quantities greater than 500g and has been commercialized by PPTI as 
ProNectin F@. Progress has also been made in the cloning and expression of fragments of the silk 
proteins from midges (Chironomus tentans) and spiders. Midge larvae spin insoluble fibers 
consisting in part of a family of silk proteins designated spI, which contain ca. 150 copies of an 82 
residue core repeat. The spI are very large proteins, ca. 1MDa. Steven Case and his colleagues at 
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the University of Mississippi have prepared synthetic oligonucleotides which encode the 82 
residue core repeat, and have reported successful expression of these oligonucleotides in E. coli 
under control of a bacteriophage T7 promoter. lo The protein has been purified to homogeneity 
and is being used to study the mechanisms of fiber assembly. Spider dragline silk from the golden 
orb weaver (Nepila clavipes) is produced as fibers which are stronger than those of high-strength 
synthetic aromatic polyamides such as ~ev la r@.  l l Randolph Lewis and coworkers at the 
University of Wyoming have cloned genes encoding various spider silk proteins and attempts to 
express these proteins in E. coli are in progress. l 2  
Collagen 
Collagen makes up as much as one fourth of all the proteins in mammals. It is the major 
constituent of connective tissues and thus acts as the main load bearing, soft tissue component. 
Collagen fibers consist of bundles of triple helical proteins held together through extensive 
hydrogen bonding. The individual strands of the triple helices are constructed from many repeats 
of the tripeptide sequence (-GlyProXxx-) where Xxx can be any amino acid, but is usually proline 
or trans-4-hydroxyproline. The proline residues favor extended conformations of the polypeptide 
chains which are further stabilized by the intertwining of two additional protein strands. The 
glycine residues allow close packing of the three strands favoring formation of intrastrand 
hydrogen bonds and close packing of triple helical bundles. 
Ina Goldberg and coworkers at Allied Signal, Inc. have prepared artificial genes which encode 
repetitive proteins (-GlyProPro-), analogous to natural collagen sequences. 13 The synthetic genes 
have been cloned in E. coli using the thermally inducible promoter, hpL. A 22 kDa polypeptide was 
successfully synthesized, but u~lless the heat-shock response of the E. coli host is altered, the 
protein is proteolytically degraded. The protein can be stably produced in mutants that have 
impaired protein degradation systems. Cappello and coworkers at PPTI have also created artificial 
genes based on human collagen for preparation of collagen-like polymers.6 In E. coli, they have 
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successfully expressed these genes to prepare polymers ranging in size from 40 to 70 kDa. The 
properties of these materials have not been extensively explored to date. 
Elastin 
The 72 kDa protein tropoelastin is a precursor of the protein elastin, which provides the 
elastic properties of mammalian arteries, lungs, skin, and other tissues. l4 The tropoelastin sequence 
consists of tandem repetitions of a number of oligopeptide blocks which are four to nine amino acids 
in length. A synthetic analog of one of these blocks has been elaborated into a polymeric material 
which exhibits extraordinary elasticity. This material contains the block (-ValProGlyValGly-) which 
forms a type I1 beta reverse turn around the proline-glycine dipeptide.15 The amino acids not 
participating in the turn span the distance between turns, with glycine acting as a spacer of high 
flexibility. When the turns are linked together they wind into a spiral that functions as a molecular 
spring, resulting in a material that can be extended to over 300% of its resting length with no 
deformation. 15 
A tropoelastin cDNA has been cloned and expressed in E. coli by Joel Rosenbloom and his 
colleagues at the University of ~ennsylvania.16 Since the fiee polypeptide is rapidly degraded in 
E. coli, it is necessary to express a fusion protein of tropoelastin linked at its N-terminus to an 8 1- 
amino acid fiagrnent of Influenza virus NS 1 protein. CNBr digestion can then be used to isolate 
the tropoelastin portion if a methionine codon is included at the junction of tropoelastin with the 
virus protein. (Tropoelastin contains no internal methionine residues.) The purified recombinant 
tropoelastin cross reacts with antibodies to elastin-like peptides and exhibits chemotactic activity 
toward fetal calf ligament fibroblasts.16 Recently McPherson, et al.17 have described the 
biosynthesis of an analogue of the core repeat of mammalian elastin, [Gly-(Val-Pro-Gly-Val- 
G1y)lg-Val-Gly-Pro-Gly], in E. coli. 18 The target protein was isolated in high purity and 
exhibited spectroscopic properties identical to those of chemically synthesized samples. 
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Adhesive Proteins 
Many marine organisms (e.g. barnacles, mussels, and tube worms) secrete adhesive 
proteins for surface attachment or for physical protection.8 These adhesives are remarkable in 
that they can be spread on a surface immersed in salt water and form a permanent bond within 
seconds. The bond will also withstand a wide range in temperature and large fluctuations in tidal 
currents. Since many man-made adhesives are ineffective in wet environments, the development 
of commercial adhesives based on these proteins is an attractive option. Although marine 
adhesive proteins from different organisms have different amino acid sequences, they all have a 
high percentage of DOPA (3,4-dihydroxyphenylalanine) residues which are present in repetitive 
sequences of 7 to 10 amino acids in length.8 The DOPA residues are created by post-translational 
hydroxylation of tyrosine in precursor proteins and are thought to be primarily responsible for 
the adhesive properties of the polymers. In situ enzymatic oxidation of the DOPA residues to 
quinones is thought to result in cross-linking of the materials and their adhesion to surfaces.18 
Robert Strausberg and coworkers at Genex Corporation have isolated a cDNA clone fiom 
the marine mussel Mytilus edulis that consists of 20 repeats of 
(-AlaLysProSerTyrProProThrTyrLys-), the putative adhesive sequence. They have expressed this 
protein and several of its multimers, e.g., dimers, trimers and tetramers, in Saccharomyces 
cerevisiae by using an expression vector containing a promoter comprised of portions of the S. 
cerevisiae GAL 1 and MF-a 1 promoters.19 This expression system is efficient enough to produce 
the recombinant proteins in amounts corresponding to about 3-5% of the total cell protein. These 
proteins are all insoluble; the largest having a molecular weight of ca. 96 kDa. The purified 
precursor proteins do not show adhesive properties until they are treated with a bacterial 
tyrosinase, which converts tyrosine residues to DOPA. 
A synthetic gene encoding an analog of the mussel adhesive protein has been constructed by 
Anthony Salemo and Ina Goldberg of Allied Signal. A DNA sequence encoding 20 copies of the 
decapeptide adhesive sequence was constructed by polymerization of a 30-base pair DNA monomer; 
the codons were chosen to correspond to E. coli use patterns and expression was controlled by the 
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bacteriophage T7 promoter.20 The resulting recombinant protein accumulated in intracellular 
inclusion bodies and could be isolated in amounts approaching 60% of total cellular protein. When 
this material is mixed with niushroom tyrosinase, it forms an adhesive which can be spread on 
surfaces and used for cell attachment and growth. The adhesive has also been shown to be effective in 
forming a gas permeable seal when used as a cement for wet ocular tissue samples.21 
Viral Proteins 
Human adenoviruses are believed to attach to host cells via fibrillar protein spikes located on 
the surface of the viral ~ a p s i d . ~ ~  The 200 A long spikes consist of a repetitive 62 kDa protein 
organized into a trimeric array which is about 30 A in diameter. The secondary structure of the 
protein has not yet been determined although triple helical and cross-beta models have been proposed. 
The potential for producing polymers which could be processed into high performance fibers through 
self-assembly makes the synthesis of analogues of these viral spike proteins an attractive prospect. 
The 35 kDa fibrous protein fiom adenovirus serotype 3 has been expressed in E. coli by 
Corinne Albiges-Rizo and Jadwiga Chroboczek of the European Molecular Biology Laboratory. The 
product is a fusion protein containing at its N-terminus a short leader sequence derived fiom the 
cloning vector based on bacteriophage T7.23 The recombinant protein was insoluble and appeared as 
a trimer when subjected to gel electrophoresis under denaturing conditions. Since the naturally 
occurring viral protein and the recombinant protein exhibit similar gel filtration behavior, Albiges-Rizo 
and Chroboczek have suggested that the native viral fiber also consists of a trimeric protein 
assembly? 
John O'Brien and coworkers at E. I. du Pont de Nemours and Co. have expressed synthetic 
analogs of viral spike proteins in bacterial systems? Oligonucleotide sequences encoding three 
synthetic analogs consisting of polypeptide repeats of 15 residues were prepared, multimerized 
and cloned in E. coli. The polypeptide repeat sequences were designed to contain reverse beta 
turns of either 4 or 5 residues and two short (three residue) beta strands. The resulting expressed 
proteins formed inclusion bodies and ranged in molecular weight from 20 to 100 kDa. All of the 
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proteins were soluble in l~exafluoroisopropanol (HFIP). Most interesting is the observation that 
HFIP solutions of several of these polymers were birefiingent, suggesting that liquid crystalline 
phases were formed. Fibers were drawn from the anisotropic solutions and were shown to have 
mechanical properties similar to those of textile fibers in commercial use. 
Coiled-coil Proteins 
A family of polymers analogous to the protein transcription factors GCN4, Fos and Jun 
has been expressed in bacterial systems by Kevin McGrath and David Kaplan of the U. S. Army 
Natick Research, Development and Engineering Center? The transcription factors form coiled- 
coil structures consisting of two intertwined helices with a superhelical pitch of ca. 140 A.26 The 
amphiphilic helices assemble with the hydrophilic residues facing the solvent and helping to 
stabilize the assemblies by forming interchain electrostatic interactions; the hydrophobic residues 
are located on the inside of the coil. Heterodimerization of the protein chains is encouraged by the 
specific design of the artificial polypeptide sequences. Although these studies are at an early 
stage, the project has the potential for creating materials capable of self-assembly into complex 
structures and intermolecular recognition. 
DE NOVO DESIGN AND SYNTHESIS OF WELL-DEFINED POLYPEPTIDES 
Design Methodology 
Previous research in this area initially had two major goals. The first was to evaluate the 
feasibility of using genetic engineering to create proteins with materials potential. Natural proteins 
known to have excellent materials properties were purposely set aside in favor of testing the potential 
of creating new proteins ab initio. These proteins would be designed from first principles utilizing 
structural elements found in natural proteins and their simpler analogs, namely beta strands, reverse 
turns and alpha helices. The second key objective was to assess the extent to which protein chain 
folding and supramolecular organization could, in fact, be controlled at the molecular level. Judicious 
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utilization of the compositional and sequential control available through biocatalytic synthesis should 
yield materials with precisely-defined structures. 
Two classes of proteins have been featured in this work (Table 1). One consists of periodic 
chain-folding proteins designed to form crystalline lamellar solids. Nearly all flexible, stereoregular 
polymers crystallize in the form of lamellar aggregates in which the chain is oriented normal (or nearly 
normal) to the lamellar plane and folds regularly at the lamellar surface.27 The thickness of such 
crystals is determined primarily by the kinetics of crystallization. Through proper sequence design, it 
has become possible to construct polymer chains fiom elements that are known to form antiparallel 
beta sheets and that allow control of the thickness and surface chemistry of lamellar polymer crystals. 
The second class of materials under study consists of proteins predicted to form alpha helices. 
Poly(a,L-glutamic acid) (PLGA) and related polymers have played a central role in investigations of 
the physical chemistry and materials science of chain molecules.2* Studies of this rod-like molecule 
are complicated, however, by the polydispersity of chain lengths obtained when this polymer is 
prepared synthetically. Our research efforts have concentrated on the production of monodisperse 
variants of PLGA and poly(a,L-aspartic acid) to overcome these synthetic limitations. 
More recent research in this field has branched into an additional area which serves extend the 
original goals. This new focus, and the subject of the next section, concerns the use of intact cellular 
protein synthesis machinery to incorporate unnatural amino acids into some of the artificial proteins 
described above. Unnatural amino acids (or amino acid analogs) allow the incorporation of unusual 
atoms and functional groups (e.g. fluorine and electroactive groups) into proteins, and extend the range 
of properties obtainable for protein materials. 
Folding Beta Sheet Proteins 
The formation of folded-chain lamellar crystals is common among polymers of regular 
chemical structure. For most such materials, however, the folded-chain structure is determined by 
the kinetics, rather than the thermodynamics, of the crystallization process, and the observed 
lamellar organization is metastable. The opportunity to design sequences of controlled periodicity 
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offers the prospect of thermodynamic control of regular chain folding. Our approach has been to 
attempt to exploit known sequence-dependent secondary structures (e.g., beta strands and reverse 
turns) to design folded-chain lamellar crystals of controlled thickness and surface functionality. As 
shown schematically in Figure 3, the thickness of the crystal is controlled by the length of the 
extended element (the beta strand), while the surface functionality is determined by the composition 
of the turn sequences. 
Glycine-alanine (Gly-Ala) dyads are featured in the stem segments of our periodic proteins as 
this motif is known to f o m ~  beta strands. GlyAla repeats are responsible for the beta sheets 
characteristic of the silk-I1 crystal morphology as well as the beta strands in type-I poly-~laGly.29 
One of the design variables under study is the effect of the stem length on lamellar dimensions (vide 
infra). A variety of turn structures is also under study. 
The first proteins to be constructed contained proline and glutarnic acid in the turn sequences 
since proline is a well known turn-former and the bulky, polar glutarnic acid residue should be 
excluded from the crystalline interior by both steric interactions and solvent-binding effects? 
Crystalline solids have been obtained for several sequences of this type (Table I), but the formation 
of regular lamellae is dependent on the size of the basic repeat unit (vide infra). A library of genes 
encoding several different two-amino acid tum sequences has been constructed, based on sequences 
reported for the type-I' and type-11' reverse turns found in natural proteins. The anticipated solid- 
state organization of these polymers would thus be characterized by regular folding of the chain at the 
turn sequences, with the glycylalanine beta sheets stacked in the lamellar interior and the turn 
sequences exposed at the surface. The first repetitive copolypeptides that we designed were 
multimers of either the nonapeptide [(Gly~la)3Gly~roGlu]7 1 or the undecapeptide 
[(GlyAla)4GlyProGlu] ,3 2. Chain-length variants containing 10-54 repeats of the above sequences 
have been efficiently produced in E. coli using a bacteriophage T7-based expression system. Although 
several lines of evidence indicate that the expressed proteins have the correct sequence, such materials 
do not readily adopt regularly folded chain arrangements, but instead form amorphous glasses at room 
temperature. 
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In a second attempt at sequence-controlled crystallization, a gene encoding thirty-six 
repeats of the octapeptide [(GlyAla)3GlyGlu] 3 was expressed in E. coli as a fusion protein 
containing short flanking sequences derived from the cloning and expression vectors.32 The target 
protein was confined to the soluble fraction of the whole cell lysate, and a simple procedure 
involving sequential pH adjustments with glacial acetic acid afforded a substantial enrichment in 
the supernatent. The product was isolated by ethanol precipitation at -10 C, and the periodic 
portion of the target protein was liberated fkom the flanking sequences by cleavage with cyanogen 
bromide. The predominance of the antiparallel beta sheet structure in the crystalline polypeptide 
is revealed in the key features of the infiared (IR), Raman, and cross polarization magic angle 
spinning nuclear magnetic resonance (CP/MAS NMR) spectra of samples crystallized from 70% 
formic acid? The IR spectrum of 3 exhibits amide I, 11, and 111 vibrational modes at 1623, 1 52 1, 
and 1229 cm-1, respectively, characteristic of the beta sheet conforrnation, and the weak amide I 
a component at 1698 cm-1 indicates the regular alternation of chain direction that defines the 
antiparallel beta sheet architecture. The Raman spectrum of 3 exhibits the arnide I band at 1664 
cm-1 and the splitting of the arnide I11 band into two components at 1260 and 1228 cm-1, 
characteristic of the antiparallel beta sheet conformation. Likewise, the CP/MAS 1 3 ~  NMR 
spectrum of 3 showed chemical shifts analogous to those obtained for poly(L-AlaGly) in the beta 
f0rm.3~ 
Wide-angle x-ray diffraction patterns of crystal mats of 3 were obtained with the x-ray beam parallel to 
the plane of the mat. The diffraction patterns exhibit discrete Bragg reflections consistent with a 
crystalline polymer and the reflections index on an orthorhombic unit cell with dimensions a = 0.948 
nrn, b = 1.060 nm, and c (chain axis) = 0.695 nm. These unit cell parameters are commensurate with 
previously published x-ray diffraction results from various silk fibroins and synthetic polypeptides 
that exhibit similar crystalline structures.33 In addition, well-defined meridional reflections were 
observed which correspond to a long period spacing of 36 A. This result appears to be completely 
consistent with the expected lamellar thickness, since molecular modeling predicts a spacing of ca. 33 A 
between the termini of glutamic acid side chains arrayed on opposite faces of crystals built up from 
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stacked, folded beta sheets of 3 (Figure 4). A long-period spacing of 36 A would thus correspond to an 
interlamellar separation of ca. 3 A, which appears plausible. Electron microscopy of 3 reveals 
individual lamellae ca. 1 pm in length, generally similar in appearance to crystals grown from 
conventional nylons.32 All of the experimental evidence collected on the solid-state structure of 3 (and 
other stem length variants of 3) strongly supports a crystalline antiparallel beta sheet architecture 
involving a chain-folded lamellar structure as the basic crystalline unit. 
Other stem-length and turn sequence variants of 3 are also under investigation. One variant in 
particular is the sequence [(AlaGly)~GluGly(GlyAla)~GluGly], 4 which was synthesized to probe 
the chain folding pattern in the polymeric crystalline d0mains.3~ None of the diffraction analyses 
mentioned above directly addresses the nature of chain folding, yet successful assembly of the 
predicted lamellar structures depends on the ability of the chains to fold and crystallize in an adjacent 
reentry fashion. Polymers comprising 10 repeats of sequence 4 were expressed in E. coli under 
conditions where 13C-enriched glycine and alanine could be incorporated into the chains. Mared  
spectra of blends of natural-abundance and 13~-enriched polymers of sequence 4 showed two bands in 
the polypeptide amide I region (1 629 and 1596 cm-1) assignable to hydrogen-bonded beta sheets of the 
isotopically distinct samples. It has been suggested that the frequency shift of the unperturbed arnide I 
vibration is due to transition dipole coupling between adjacent carbonyls within the beta sheets. Hence, 
the presence of separate 13C and 1 2 ~  derived amide I bands (instead of a composite band) led us to 
propose that a majority of the chains are folding in an adjacent reentry fashion as predicted? 
Monodisperse Alpha Helical Proteins 
Polymers that adopt a persistent rodllke structure in solution and in the solid state have 
been a topic of much current research in materials science? These materials should form ordered 
solutions due to the shape anisotropy of the individual rods thereby facilitating their fabrication 
into oriented solid materials. Polypeptides that adopt a persistent a-helical secondary structure 
should display this behavior for structures that have a critical aspect ratio of rod length to 
diameter. Indeed, studies of poly(a,L-glutamic acid) (PLGA) and its ester derivatives have 
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played a central role in elucidating the physical chemistry and materials science of rodlike 
polymers.28 PLGA itself has been used in fundamental studies of the helix-coil transition of 
polyele~trolytes,~~ and ester derivatives of PLGA most notably poly(y-benzyl-a,L-glutamate) 
(PBLG) form organic liquid crystalline solutions37 and oriented monolayer films? In addition, 
a-helical rods should have a large dipole moment associated with the peptide bond that is 
essentially oriented along the helical axis.39 The dipoles of individual PBLG helices can be 
oriented in solution under the influence of an electric or a magnetic field affording ferroelectrically 
ordered mesophases and films.40 These materials display properties associated with oriented 
acentric materials such as piezoelectric behavior and second order non-linear optical properties. 
The traditional synthetic route to PLGA and its esters involves the ring-opening 
polymerization of N-carboxy-a-amino acid anhydrides. This technique affords a heterogeneous 
population of chains that have relatively broad distributions of molecular sizes. This 
heterogeneity of molecular lengths complicates the assessment of the critical structural criteria for 
the observation of liquid crystallinity in rodlike polymers, which remains an open question. The 
utility of these materials in the design and construction of complex macromolecular architectures 
also is limited by this structural heterogeneity. The incorporation of more complex sequences of 
residues in a rational manner is also clearly precluded via this synthetic approach due to the 
inability to accurately specify the positions of individual residues. 
Uniform length a-helical rods of a PLGA analogue [GluAsp(Glu~~Asp)~G1uGlu], 5, have 
been prepared via a genetically directed synthesis.41 The periodic aspartic acid residues provide 
recognition and cleavage sites for the restriction enzyme BbsI, which is used to liberate the coding 
sequence for head-to-tail oligomerization of the oligonucleotides. Aspartic acid was chosen as the 
second residue because of its similarity to glutarnic acid, which is expected to reduce to a 
minimum any perturbation of the chemical and physical properties of the chain. The gene for 5 
was expressed as a fusion protein to the affinity label glutathione-S-transferase, which enabled a 
convenient separation from the bacterial host proteins by chromatography. The target 
polypeptide was liberated from the fusion protein by either enzymatic proteolysis or cyanogen 
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bromide cleavage. The PLGA analogue 5 displays chemical and spectroscopic properties 
consistent with its expected structure, in particular, a pH dependence of its circular dichroism 
spectrum indicative of a helix to coil transition upon deprotonation at alkaline pH. In addition 
the electrophoretic behavior of 5 compares favorably with commercial samples of narrow 
polydispersity (polydispersity index = 1.2), chemically synthesized PLGA. The latter samples 
appear as broad smears while the former appears as a single, tightly focussed band, thus 
illustrating the power of the biosynthetic strategy for the control of macromolecular architecture. 
Monodisperse 5 has been cleanly converted to its benzyl ester derivative 6 by alkylation 
of the carboxylate groups with phenyldiazomethane. GPC analysis of the product indicates that 
the uniformity of 5 is retained during the benzylation. Spectroscopic analysis of 6 is consistent 
with chemically synthesized samples of PBLG. The uniform polyglutamates should generate 
unique liquid crystalline phases because the polymer's uniform chain length should allow it to 
stack into a phase with both orientational and positional order. In contrast, the polydisperse 
polymer lacks positional order and forms a more limited range of liquid crystalline structures. 
Solutions of 6 in benzyl alcohol form optically birefringent phases characteristic of lyotropic 
liquid crystalline solutions of rodlike polymers. The effect of the uniformity of the polypeptide 
on the degree of order displayed by the liquid crystalline phases is currently under investigation. 
INCORPORATION OF ARTIFICIAL AMINO ACIDS INTO PROTEINS 
Me thodology 
While biological synthesis offers superior control over polymer chain architecture, including 
purity of sequence, size and stereochemistry, its versatility is normally limited to the twenty amino 
acids that appear in natural proteins. Thus, an important aim for the future will be to expand the 
number of amino acids that can be utilized in protein biosynthesis. First efforts in this direction 
would logically start with amino acid analogs known to be incorporated during t r an~ la t i on .~~  The 
unnatural amino acids (or amino acid analogs) employed are those which are in many ways similar to a 
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natural amino acid, yet differ slightly in structure (thienylalanine vs. phenylalanine), functionality 
(hydroxyproline vs. proline), or constituent atoms (selenomethionine vs. methionine) (Tables 2 and 
3). 
The biosynthesis of proteins containing non-natural amino acids has been approached in three 
different ways. One approach involves attaching a desired substituent to a suppressor tRNA that 
decodes a nonsense codon in an appropriate location in the gene of intere~t.~3 This approach allows 
the usual restrictions on enzymatic charging of tRNA to be by-passed; it also permits the non-natural 
monomer to be introduced into a specific site. However, only sub-milligram quantities of protein are 
likely to be obtained, since chemical acylation is experimentally difficult and the tRNA is not 
recycled. Furthermore, since the efficiency of suppression generally is 50% or less, multi-site 
replacement (for example, in a repetitive protein) is impractical. In a second method, the amino acid 
analogue is added to a cell-fiee protein synthesis system.44 Only substrates that can be 
enzymatically activated and charged can be used, but the method avoids the difficulties of low 
suppression efficiency and chemical synthesis of the aminoacyl tRNA. The third approach, which 
provides the potential for synthesizing proteins contahling many modified sites, is in vivo 
incorporation of non-natural amino acids. 
It has been known for many years that certain analogs of the natural amino acids can be 
incorporated efficiently in vivo into bacterial proteins? Success of this process is entirely 
dependent on the ability of the protein synthesis machinery of the cell to accept the analog in place of 
the natural amino acid. The artificial amino acid must first enter the cell; however, because the 
relevant transport processes are usually not very specific, transport is not normally limiting to analog 
incorporation.45 Much more important are the aminoacyl-tRNA synthetases, which are responsible 
for recognition of the 20 natural amino acids and attachment ("charging") to their respective ~ R N A S . ~ ~  
The non-natural analogs must be similar enough to their natural counterparts to be recognized and 
activated by these enzymes. In addition, a certain lack of specificity is desirable in the aminoacyl- 
tRNA synthetase enzyme for the amino acid of interest: the less specific the enzyme, the greater the 
range of analogs which can be successfully incorporated. 
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Since the synthetase enzymes are nearly always much more effective in activating the natural 
amino acid than the analog, it is often crucial to decrease the amount of natural amino acid available to 
the cells. This requirement is met through the use of host strains which are amino acid auxotrophs, 
i.e., cells which require a certain amino acid ( the one of interest for analog incorporation) in order to 
grow. Thus, our methodology for incorporating non-natural amino acids into artificial proteins begins 
with the preparation of a suitable E. coli auxotroph47 followed by transformation of this strain with 
an expression vector containing the gene encoding the target protein of interest with the natural amino 
acid encoded in the positions where the analogs are to be inserted. If the amino acid analog supports 
cell growth, the cells can then be grown in medium lacking the natural amino acid, but supplemented 
with the analog of interest. Expression of the target protein is then induced and the protein is isolated 
by standard methods. If the analog is toxic to the cells or does not support growth, an alternate 
procedure is employed; the cells are grown in medium containing the natural amino acid, they are then 
pelleted, washed, and resuspended in medium containing the analog and laclung the natural amino acid, 
and protein expression is induced. This procedure is necessary to grow large numbers of cells for 
production of sufficient quantities of target proteins. 
Incorporation of Selenomethionine 
In a first attempt to generate artificial proteins containing non-natural amino acids, we 
produced a beta sheet forming protein containing selenomethionine.48 The protein was expressed in 
E. coli from plasmid DNA that encoded a lamellar protein of sequence [(GlyAla)sGlyMet] 1 1, 7. 
Selenomethionine was selected for two reasons: first, it is known to support growth of E. coli 
methionine auxotrophs in the absence of externally supplied methionine;39 second, the presence of 
selenomethionine endows product proteins with useful sites for chemical modification and a 77Se 
NMR probe useful for mapping local folding properties. In addition, the selenium containing side 
chains can be utilized selectively for addition of structurally or functionally important new 
substituents or for site-specific linkage to other materials. 
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The target protein used in our study contains methionines in each putative beta-turn 
segment, offering the potential of selective placement of selenomethionines on the surfaces of a 
resulting lamellar material. This prediction is supported (but certainly not conclusively 
demonstrated) by x-ray scattering data obtained with the methionine containing product, showing 
that this material assumes a crystalline m0rphology.~8 An E. coli expression strain was first 
converted to a strict methionine auxotroph and shown to grow in medium in which methionine was 
replaced with selenomethionine; although the growth rate was slower with the analog, similar 
saturating cell densities were observed.48 Electrophoretic analysis showed that the target protein 
was produced in cells grown on selenomethionine and that no inhibitory effects on protein 
production were observed. The level of selenomethionine substitution was estimated indirectly 
using a competition assay where the loss of radiolabeled methionine in product protein was 
correlated with the ratio of methionine and selenomethionine in the growth medium. The results 
were consistent with perfect or near-perfect replacement of methionine with selenomethionine. 
Plans for future work include characterization of the crystalline morphology of the analog containing 
material and chemical modification studies. 
Fluorine containing polypeptides 
Another area of interest is the incorporation of fluorinated amino acid analogs. Natural 
polymers lack halogens, yet many synthetic polymers which incorporate halogens have proven to be 
extremely useful. In particular, fluorine containing polymers display the useful characteristics of . 
excellent solvent resistance, good hydrolytic stability, low surface energy, and low coefficient of 
fnction.50 We reasoned that it would be advantageous to transfer some of these properties to 
polypeptides to create unique materials which might prove useful for the fabrication of novel 
membranes, low-fnction surface treatments, and biomedical materials. Furthermore, since fluorine is 
only slightly larger than hydrogen it is not surprising that many fluorinated amino acids are recognized 
and utilized by the bacterial protein synthesis machinery.42 
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The analogs chosen for the in vivo synthesis of fluorinated polypeptides in our laboratory 
have included para-fluorophenylalanine (pfF) and 5,5,5-trifluoroleucine (TFL), since both had been 
shown previously to be incorporated into E. coli proteins.42 The strategy was similar to that used for 
selenomethionine, with the exception that the host auxotroph strains were first grown in the presence 
of the natural amino acids and then protein synthesis was induced in medium containing the analog. 
This step was necessary because these analogs did not support growth of the E. coli strains used for 
protein expression. The artificial proteins into which the analogs were inserted were, as with 
selenomethionine, lamellar proteins of the type [(GlyAla)3GlyXxx],, 8, where X a  was encoded as 
Phe for pfF (n = 13) and Leu for TFL (n = 12). 
Proteins containing pfF51 or T F L ~ ~  were expressed and purified through standard 
techniques. The extent of analog incorporation was found to be very high for both materials 
(295% for pfF and 88% for TFL) as determined by 1~ NMR spectra and amino acid analyses. 
Both materials were crystallizable and were found to adopt antiparallel beta sheet structures 
similar to those obtained for other proteins of this type (vide supra). Thus, it is expected that the 
fluorinated residues, since they occupy turn positions, will be exposed at the surfaces of the 
polymer crystals and should affect the bulk material properties of the samples. Advancing 
contact angle measurements with hexadecane for the TFL polypeptides gave increasing contact 
angles with increasing analog content relative to the natural residues. The presence of fluorine in 
the samples was found to decrease the surface energy as determined by decreased wettability 
toward hydrocarbon l iq~ids .5~  
Electroactive Substituents 
The scope of functional groups that can be incorporated into the protein backbone by 
genetic engineering has recently been extended to residues with electroactive substituents, such as 
3 -thienylalanine (3 -TA) .53 3 -Alkylthiophenes, which are structurally similar to 3 -TA, can be 
oxidatively polymerized through the 2- and 5-positions of the ring to produce polymers with 
extended p conjugation. Poly(3-alkylthiophene)~ can be electrochemically doped to form 
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conducting polymers with conductivities (2000 S cm-') that are among the highest recorded for 
organic materials .54 Copolymerization of the 3 -TA residues with 3 -allcylthiophenes can provide 
a method for the crosslinking (or grafting) of polypeptides onto electrodes via a layer of 
conducting polymer that may be useful for the fabrication of enzyme-based sensory elements. 
Prior to this work, 3-thienylalanine had not been shown to be utilized by the protein 
synthesis machinery of E. coli, although the isomeric 2-TA had been incorporated into native 
bacterial proteins in place of phenylalanine. Therefore, the target protein. selected for the 
incorporation assay was the sequence, [(GlyAla)gGlyPheIl3 9, which contains a unique Phe 
residue in each repeat, which can serve as an accepting site for 3-TA. The chain-folded structure 
of the polypeptide could potentially control the spatial orientation of the electroactive 
substituents and facilitate conversion of these groups to an oriented conducting polymer. In vivo 
radiolabelling experiments demonstrated that the analogue-containg target protein was expressed 
at levels similar to the natural variant 9 in a Phe auxotroph. The extent of substitution, 
quantitated by UV and 1~ NMR spectroscopy, and amino acid analysis, is about 80%, 
suggesting that 3-TA is efficiently utilized by the E. coli protein synthesis machinery under these 
conditions. Preliminary electrochemical investigations indicate that the 3-TA-containing 
polypeptide can be oxidatively copolymerized with 3-methylthiophene yielding conductive 
films. 
Struclral Modifications of Polypeptides 
It was mentioned earlier that a key to successful in vivo analog incorporation is lack of 
specificity in the aminoacyl tRNA synthetases. The prolyl-tRNA synthetase has been reported to be 
the least specific of all? Not only does this mean that a wide variety of proline analogs should be 
incorporated into proteins, but proline, the only irnino acid, is also a key residue for structural 
modification studies. The lack of a hydrogen atom on nitrogen to serve as a hydrogen bond donor, 
coupled with the steric bulk of the prolyl ring, in almost all cases excludes proline from involvement 
in a-helical and P-sheet structures .56 Proline therefore usually occupies the key positions of hehx 
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starter or helix terminator, and plays an active role in protein folding. It has also been reported that 
proline can act to bend the axis of a helix by ca. 30 . Finally, although it is a hydrophobic residue, 
proline is usually exposed at the hydrophilic surfaces of proteins by virtue of its localization in turns. 
This is an ideal location if reactive analogs are to be accessible for post-translational modification. 
It was thought that analogs of proline might cause significant perturbations in the solid-state 
structure of polymers of the sequence [(GlyAla)3GlyProGlu] 1 (vide supra). Although these 
polypeptides crystallize with difficulty, it was proposed that substitution of an analog for proline 
might facilitate crystallization of the AlaGly repeats into a lamellar P-sheet architecture. Of key 
interest was incorporation of homologs of proline, where a simple change in the size of the ring 
structure would cause a significant change in the conformation of the residue and thus allow chain 
folding. As precedent for this, it has been reported that incorporation of L-azetidine-2-carboxylic acid 
in place of proline at levels as low as 4% is sufficient to prevent triple helix formation in collagen? 
Many analogs of proline have been reported and some have been demonstrated to be 
incorporated in vivo into cellular proteins? These results are briefly summarized in Table 3. The 
bulk of studies on analogs of proline have focused on collagen synthesis,59 although a few reports 
exist on the behavior of these analogs in bacteria.60 The proline analogs used in our studies began with 
some of those which had been previously incorporated into proteins, namely: L-azetidine-2- 
carboxylic acid ( A Z C ) , ~ ~  L-y-thiaproline (~hp),61 and 3,4-dehydroproline ( ~ h ~ ) 6 2 .  As can be seen in 
Table 3, Azc, Thp, and Dhp have all been incorporated into proteins in E. coli cells in vivo. 
A proline auxotroph of E. coli containing a gene encoding sixteen repeats of 1 was used for the 
expression of proteins containing the analogs.63 Proteins containing varying degrees of Azc, Thp, and 
Dhp were expressed and purified. Dhp appeared to be utilized most efficiently with incorporation 
levels approaching 100%. Azc was incorporated to a lesser extent (ca. 40%) and Thp was 
incorporated to a level of around 10%. The physical properties of the Dhp variant were found to be 
very similar to those of the proline form: both formed amorphous solids and were very soluble in 
water. Wlule the material containing Dhp is amorphous, it is an intriguing material which contains 
olefinic functionality which can serve as a site of specific reactivity not present in natural proteins. 
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Both the Thp and Azc variants were found to be water insoluble, and the Azc material 
fractionated differently from the parent material during purification. The decreased solubility of these 
polypeptides is an indication that they may be crystalline; a hypothesis supported for the Azc 
material by preliminary structural studies. These proteins illustrate the use of small specific variations 
in monomer structure to control and vary the overall conformation of the chain. 
HYBRID ARTIFICIAL PROTEINS 
Design Criteria 
The coupling of natural and artificial domains to produce hybrid artificial proteins offers the 
prospect of new classes of fimctionalized nanoscale architectures. In preliminary experiments 
directed toward these objectives, enzymes have been linked at the genetic level to crystalline artificial 
proteins to promote the assembly of catalytic arrays and sensors (Figure 5). In designing materials of 
this type many issues relating to the composition of the natural and artificial domains must be 
addressed. Choice of the artificial domain in our initial experiments was simple: we sought a 
polypeptide which would present functional groups useful in surface assembly and attachment. Such 
functional groups might include the ammonium groups of lysine (which can attach to anionic 
surfaces), the sulfhydryl groups of cysteine (which can bind to gold surfaces), and the carboxylate 
groups of glutamate and aspartate (which can be attached to cationic surfaces). A polypeptide which 
fulfilled all of these requirements was the repeating octapeptide 3 which is expressed in high yield in 
E. coli. 
The enzyme comprising the natural domain of the hybrid protein must satisfy a more complex 
set of requirements. The enzyme should function as a single-subunit, so that post-translational 
association of enzyme subunits, common in many enzymes, is not essential. It must express well in 
appropriate cellular hosts, and it must tolerate modification (i.e., fusion to the artificial domain ) 
without loss of function. Our first candidate was a single chain phosphotriesterase from 
Pseudomonas diminuta which hydrolyzes many phosphorus based pesticides and nerve agents.64 
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This enzyme should be useful in detection and decontamination of these toxins, it has been cloned and 
expressed in E. coli, and it was available in plasmid-encoded form at the outset of our experiments.65 
Results 
A gene encoding both the 27 kDa artificial protein of sequence 3 and the 39 kDa 
phosphotriesterase domain was constructed and expressed in E. coli using a bacteriophage T7-based 
expression system.66 The enzyme itself was also expressed in E. coli and was found to form 
inclusion bodies which segregate into the insoluble portion of the cell lysate. The fusion protein was 
found to segregate into the soluble portion of the cell lysate which should help to reduce problems 
involved in renaturing the enzymatic portion of the protein. Fractionation experiments on an ion- 
exchange column showed that the fusion protein could be effectively separated from the fiee enzyme 
based on the excess acidic sites present in the artificial domain. Furthermore, these sites were 
sufficient to bind the fusion protein to the column under conditions where the fiee enzyme is not 
bound, and preliminary results suggest that enzymatic activity is retained. Current work is aimed at 
immobilizing the fusion protein onto optical glass fibers to create biosensor devices. 
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Scheme I. Iterative Step Growth 
X-Y 
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Scheme 11. Template Polymerization 
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Table 1. Repeating Units of Periodic Polypeptides Currently Under Study 
Repeating Unit Interest Statusa 
(GlyAla), GlyProGlu 
(GlyAla), GlyGlu 
(GlyAla)3GlyZ 
(GlyAla), GlyZGlu 
(GlyAla)3 GlyGlu(AlaGly)3 Gly Glu 
on crystal structure and morphology 
(GlyAla)3GlyGlu(GlyAla)3 GlyVal 
(GlyAla)3GlyGlu(GlyAla)3 GlyMet 
Glu 1 7Asp 
Sequence-dependent A ( x = 3 ,  4, 5, 6, =) 
chain folding 
Turn requirement for A (XY = GlyLeu, GlySer, 
folded-chain lamellae Gly Val, GlyMet, 
SerGly, GlyAsp, 
GlyTyr, Gly Asn, 
GlyPhe, Gly Thr) 
Correlation of chemical and 
spatial periodicity 
Incorporation of non-natural 
' amino acids 
Effect of stem sequence polarity 
Differentiation of lamellar 
surface functionality 
B (XY = 10 additional pairs) 
Monodisperse poly(g1utamic acid) 
and mesogenic poly(y-benzyl-L-glutamate) 
a A: Protein expressed and isolated; 
B : Coding sequence prepared and cloned. 
Z = L-selenomethionine, p-fluorophenylalanine, 5,5,5-trifluoroleucine, 3-thienylalanine. 
Z = azetidine-2-carboxylic acid, thiazolidine-4-carboxylic acid, 3,4-dehydroproline. 
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Code 
Table 2. Unnatural Amino Acid Analogs Incorporated into 
[(GlyAla) 3-XxxGly] . 
p-FP 
TFL 
3 -TA 
Structure Name 
selenomethionine 
p- fluoropheny lalanine 
Previous E. coli 
Incorporation 
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Table 3. Analogs of Proline Under Study 
Code 
Azc 
Pip 
DhP 
T hP 
~ - H Y P  
Sar 
Nip 
Deming et al. 
Pro 
Previous E. colt' 
Incorporation 
Yes 
no 
Yes 
Yes 
Yes 
no 
no 
no 
no 
Structure 
0 
QT 0 H ti 0 
$OH 0 
N QT 0 H 
H O  
H O  
&OH ti 0 
H O  
&OH ti 0 
\ 
N T O ~  
H 0 
H' N% 0 H 
0 
0 H 
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Name 
azetidine-2-carboxylic acid 
piperidine-2-carboxylic acid 
3,4-dehydroproline 
thiazolidine-4-carboxylic acid 
cis-4-hydroxyproline 
trans-4-hydroxyproline 
sarcosine 
piperidine-3-carboxylic acid 
pyrrolidone-5-carboxylic acid 
Transcription 
-
DNA mRNA 
WPb' Folding, processing, 
Translation 
- 
I chain Protein 
Amino acids 
Figure 1. Schematic representation of protein biosynthesis fkom a DNA template. Reproduced 
with permission from King, J. Chem. Eng. News 1989, April 10,32. 
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DNA Monomer 
DNA Muitimers 
Fractionation 
Antibiotic 
Resistance Gene 
Expression Vector 
Start 
Recombinant 
E. coli Cell Expression Vector 
E. coli Chromosome 
\ 
Protein Production 
and Processing Target Polypeptide 
w Protein Expression 
System 
(Cell and Vector) 
Fiugre 2. Synthesis, cloning, and expression of artificial genes encoding rRepetitive 
polypeptides. 
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Extended 
(Helix or 
Figure 3. Schematic representation of a folded chain lamellar crystal of a periodic polypeptide 
built up from alternating extended and folded secondary structural elements. 
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Figure 4. Molecular graphics representation of a folded-chain lamella crystal formed fiom a 
repeating polymer of sequence 3. The blue and red "core" of the aggregate comprises the 
repeating alanylglycine &sheet portion of the chain; the green surfaces present the reactive side 
chains of the periodic glutamic acid residues. The essential elements of the structure are 
supported by the results of spectroscopic and scattering studies. Reprinted with permission 
fiom reference 32. 
Deming et al. 
Natural domain 
~ r t  ificial domain 
Figure 5. Schematic representation of a new class of reactive polymers, hybrid artificial 
proteins, which combine the catalytic or recognition properties of natural proteins with the 
materials properties of artificial proteins. In the authors' laboratories, hybrid artificial proteins 
are being evaluated as elements of enzyme-based sensors and reactors. 
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